The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation.
Publication
, Conference
Glass, C; Butt, Y; Gokaslan, T; Torrealba, J
March 1, 2018
Duke Scholars
Publication Date
March 1, 2018
Location
Vancouver, BC
Publisher
Nature Publishing Group
Conference Name
107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Citation
APA
Chicago
ICMJE
MLA
NLM
Glass, C., Butt, Y., Gokaslan, T., & Torrealba, J. (2018). The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation. Presented at the 107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), Vancouver, BC: Nature Publishing Group.
Glass, C., Y. Butt, T. Gokaslan, and J. Torrealba. “The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation.” Nature Publishing Group, 2018.
Glass C, Butt Y, Gokaslan T, Torrealba J. The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation. In Nature Publishing Group; 2018.
Glass, C., et al. The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation. Nature Publishing Group, 2018.
Glass C, Butt Y, Gokaslan T, Torrealba J. The Utility of Dual CD68/CD31 Immunohistochemistry in Improving Diagnosis of Antibody Mediated Rejection in Cardiac Transplant Patients. Platform presentation. Nature Publishing Group; 2018.
Publication Date
March 1, 2018
Location
Vancouver, BC
Publisher
Nature Publishing Group
Conference Name
107th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)